IDH2 and cholangiocarcinoma: One case of conversion of IDH1 R132C to IDH1 R132F, and one case of isoform switching to mutant IDH2, have been reported in patients with IDH1-mutated cholangiocarcinoma who developed resistance to ivosidenib19,20.